HUS
- Address
- lock Available on a paid plan
Neoplasms Research
At HUS in Helsinki, the Division of Hematology-Oncology and Stem Cell Transplantation is conducting clinical research in neoplasms, with a focus on acute lymphoblastic leukemia in infants. These studies are aimed at improving outcomes for newly diagnosed patients and strengthening long-term disease control.
- Acute lymphoblastic leukemia in infants under one year
- Research focused on improving event-free survival and overall treatment results
- Evaluation of a treatment approach compared with historical outcomes
This research area reflects a strong interest in advancing care for rare pediatric blood cancers and finding more effective ways to support young patients and their families.
Respiratory Tract Diseases Research
The site is also studying respiratory tract diseases, especially pulmonary arterial hypertension in children. The trial activity is centered on testing whether adding a new therapy to standard care can better delay disease progression and improve treatment effectiveness.
- Pulmonary arterial hypertension in children and adolescents
- Assessment of whether add-on treatment improves disease control
- Comparison against placebo to understand treatment benefit
These studies highlight a pediatric cardiopulmonary focus within HUS, with research designed to support safer and more effective care for children living with serious chronic conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 therapeutic areas and 15 of 18 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 107 other sites in Finland
Therapeutic Area Benchmark — Finland
Select a therapeutic area to compare against other sites in Finland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Finland
Market Share
Country: Finland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in HUS
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Study with Open-Label Extension Period to Assess the Efficacy and Safety of Selexipag as Add-On Treatment to Standard of Care in Children Aged ≥2 to <18 years with Pulmonary Arterial Hypertension | Actelion Pharmaceuticals Ltd. | Phase III | Not Recruiting | Feb 2020 | — |
IMP list
lock Showing 1 of 18 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Asparaginase | 1 | Unknown | 2022-12-15 | 2022-12-15 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.